Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study

Kimotho J. et al, (2024), Wellcome Open Research, 8, 350 - 350

Identification of complex Plasmodium falciparum genetic backgrounds circulating in Africa: a multicountry genomic epidemiology analysis.

Miotto O. et al, (2024), The Lancet. Microbe

Prospective clinical surveillance for severe acute respiratory illness and COVID-19 vaccine effectiveness in Kenyan hospitals during the COVID-19 pandemic.

Lucinde RK. et al, (2024), BMC infectious diseases, 24

Effects of the COVID-19 pandemic on hospital admissions and inpatient mortality in Kenya: a retrospective cohort study

Ogero MO. et al, (2024), Wellcome Open Research, 9, 582 - 582

Establishing laboratory reference ranges for adults and children in Kilifi, Kenya

Downs LO. et al, (2024)

Antibodies to PfEMP1 and variant surface antigens: Protection after controlled human malaria infection in semi-immune Kenyan adults.

Kinyua AW. et al, (2024), The Journal of infection, 89

A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda.

Ogwang R. et al, (2024), Antimicrobial agents and chemotherapy, 68

The mRNA content of plasma extracellular vesicles provides a window into molecular processes in the brain during cerebral malaria

Kioko M. et al, (2024), Science Advances, 10

R21 malaria vaccine is protective against intradermal but not intravenousPlasmodium falciparumsporozoites in a randomized controlled human malaria infection study in Kenyan adults

Kapulu MC. et al, (2024)

Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.

Rosenkranz M. et al, (2024), Life science alliance, 7

Linking Cerebral Malaria Pathogenesis to APOE-Mediated Amyloidosis: Observations and Hypothesis.

Kioko M. et al, (2024), Molecular neurobiology

Comparative performance of the InBios SCoV-2 DetectTM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations

Kutima B. et al, (2024), Wellcome Open Research, 9, 349 - 349

Utility of MALDI-TOF MS for determination of species identity and blood meal sources of primary malaria vectors on the Kenyan coast

Karisa J. et al, (2024), Wellcome Open Research, 8, 151 - 151

Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge.

Nkumama IN. et al, (2024), Immunity, 57, 1215 - 1224.e6

Safety and immunogenicity of varied doses of R21/Matrix-M™ vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-Kenya

Sang S. et al, (2024)

Tungiasis among children in Kenya is associated with poor nutrition status, absenteeism, poor school performance and high impact on quality of life.

Elson L. et al, (2024), PLoS neglected tropical diseases, 18

Feasibility, safety, and impact of the RTS,S/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi

Asante KP. et al, (2024), The Lancet, 403, 1660 - 1670

Fourth Controlled Human Infection Model (CHIM) meeting – CHIMs in endemic countries, May 22–23, 2023

Kapulu M. et al, (2024), Biologicals, 101747 - 101747

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial

Datoo MS. et al, (2024), The Lancet, 403, 533 - 544

Age-dependent acquisition of IgG antibodies to Shigella serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination.

Kapulu MC. et al, (2024), Frontiers in immunology, 15

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?